Guardant Health

Forecast & Rating27 analysts currently cover Guardant Health, with about 92.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $202.24, about 13.1% upside from the current price of $178.80. Price targets range from $105.00 to $240.00 — a wide spread, showing clear disagreement over just how much Guardant Health can rise. Historically, about 38.8% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Guardant Health closely still see room for the stock to rise. Data as of Oct 31, 2026; for reference only and not investment advice.